Year: 2020

news_6

Shionogi Launches FETCROJA® (cefiderocol) in the United Kingdom for the Treatment of Infections Due to Aerobic Gram-Negative Bacteria in Adults With Limited Treatment Options

Shionogi announces the launch of FETCROJA® (cefiderocol) in the United Kingdom (UK) for the treatment of infections due to aerobic...